Skip to main content

Advertisement

Log in

A review of metabolism-associated biomarkers in lung cancer diagnosis and treatment

  • Review Article
  • Published:
Metabolomics Aims and scope Submit manuscript

Abstract

Introduction

Lung cancer continues to be the leading cause of cancer-related mortality worldwide. Early detection has proven essential to extend survival. Genomic and proteomic advances have provided impetus to the effort dedicated to detect and diagnose the disease at an earlier stage. Recently, the study of metabolites associated with tumor formation and progression has inaugurated the era of cancer metabolomics to aid in this effort.

Objectives

This review summarizes recent work regarding novel metabolites with the potential to serve as biomarkers for early lung tumor detection, evaluation of disease progression, and prediction of patient outcomes.

Method

We compare the metabolite profiling of cancer patients with that of healthy individuals, and the metabolites identified in tissue and biofluid samples and their usefulness as lung cancer biomarkers. We discuss metabolite alterations in tumor versus paired non-tumor lung tissues, as well as metabolite alterations in different stages of lung cancers and their usefulness as indicators of disease progression and overall survival. We evaluate metabolite dysregulation in different types of lung cancers, and those associated with lung cancer versus other lung diseases. We also examine metabolite differences between lung cancer patients and smokers/risk-factor individuals.

Result

Although an extensive list of metabolites has been evaluated to distinguish between these cases, refinement of methods is further required for adequate patient diagnosis and treatment.

Conclusion

We conclude that with technological advancement, metabolomics may be able to replace more invasive and costly diagnostic procedures while also providing the means to more effectively tailor treatment to patient-specific tumors.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

References

  • ACS. (2017). Cancer facts and figures—2017 (pp. 1–76). Atlanta: American Cancer Society.

    Google Scholar 

  • Alderton, G. K. (2016). Tumour metabolism: Feeding the TCA cycle in vivo. Nature Reviews Cancer, 16, 198.

    Article  PubMed  CAS  Google Scholar 

  • Alonso, A., Marsal, S., & Julia, A. (2015). Analytical methods in untargeted metabolomics: State of the art in 2015. Frontiers in Bioengineering and Biotechnology, 3, 23.

    Article  PubMed  PubMed Central  Google Scholar 

  • Ambrosini, V., Nicolini, S., Caroli, P., Nanni, C., Massaro, A., Marzola, M. C., … Fanti, S. (2012). PET/CT imaging in different types of lung cancer: An overview. European Journal of Radiology, 81, 988–1001.

    Article  PubMed  Google Scholar 

  • Becker, D. J., & Lowe, J. B. (2003). Fucose: Biosynthesis and biological function in mammals. Glycobiology, 13, 41R–53R.

    Article  PubMed  CAS  Google Scholar 

  • Blair, S. L., Heerdt, P., Sachar, S., Abolhoda, A., Hochwald, S., Cheng, H., & Burt, M. (1997). Glutathione metabolism in patients with non-small cell lung cancers. Cancer Research, 57, 152–155.

    PubMed  CAS  Google Scholar 

  • Bruntz, R. C., Lane, A. N., Higashi, R. M., & Fan, T. W. (2017). Exploring cancer metabolism using stable isotope resolved metabolomics (SIRM). Journal of Biological Chemistry, 292(28), 11601–11609.

    Article  PubMed  CAS  Google Scholar 

  • Bull, C., Stoel, M. A., den Brok, M. H., & Adema, G. J. (2014). Sialic acids sweeten a tumor’s life. Cancer Research, 74, 3199–3204.

    Article  PubMed  CAS  Google Scholar 

  • Bushue, N., & Wan, Y.-J. Y. (2010). Retinoid pathway and cancer therapeutics. Advanced Drug Delivery Reviews, 62, 1285–1298.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Calderón-Santiago, M., Priego-Capote, F., Turck, N., Robin, X., Jurado-Gámez, B., Sanchez, J. C., & De Castro, M. D. L. (2015). Human sweat metabolomics for lung cancer screening. Analytical and Bioanalytical Chemistry, 407, 5381–5392.

    Article  PubMed  CAS  Google Scholar 

  • Cameron, S. J., Lewis, K. E., Beckmann, M., Allison, G. G., Ghosal, R., Lewis, P. D., & Mur, L. A. (2016). The metabolomic detection of lung cancer biomarkers in sputum. Lung Cancer, 94, 88–95.

    Article  PubMed  Google Scholar 

  • Carr, D. F., Alfirevic, A., & Pirmohamed, M. (2014). Pharmacogenomics: Current state-of-the-art. Genes, 5, 430–443.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Chen, Y., Ma Z., Li, A., Li, H., Wang, B., Zhong, J., Min, L., & Dai, L. (2015). Metabolomic profiling of human serum in lung cancer patients using liquid chromatography/hybrid quadrupole time-of-flight mass spectrometry and gas chromatography/mass spectrometry. Journal of Cancer Research and Clinical Oncology, 141, 705–718.

    Article  PubMed  CAS  Google Scholar 

  • Currie, E., Schulze, A., Zechner, R., Walther, T. C., & Farese, R. V., Jr. (2013). Cellular fatty acid metabolism and cancer. Cell Metabolism, 18, 153–161.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • De Molina, A. R., Rodríguez-González, A. N., Gutiérrez, R., Martinez-Pineiro, L., Sánchez, J. J., Bonilla, F., … Lacal, J. C. (2002). Overexpression of choline kinase is a frequent feature in human tumor-derived cell lines and in lung, prostate, and colorectal human cancers. Biochemical and Biophysical Research Communications, 296, 580–583.

    Article  CAS  Google Scholar 

  • De Molina, A. R., Sarmentero-Estrada, J., Belda-Iniesta, C., Tarón, M., De Molina, V. R., Cejas, P., … Casado, E. (2007). Expression of choline kinase alpha to predict outcome in patients with early-stage non-small-cell lung cancer: a retrospective study. The Lancet Oncology, 8, 889–897.

    Article  CAS  Google Scholar 

  • Deja, S., Porebska, I., Kowal, A., Zabek, A., Barg, W., Pawelczyk, K., … Mlynarz, P. (2014). Metabolomics provide new insights on lung cancer staging and discrimination from chronic obstructive pulmonary disease. Journal of Pharmaceutical and Biomedical Analysis, 100, 369–380.

    Article  PubMed  CAS  Google Scholar 

  • Delgado-Povedano, M. D. M., Calderón-Santiago, M., Priego-Capote, F., Jurado-Gámez, B., & de Castro, M. D. L. (2016). Recent advances in human sweat metabolomics for lung cancer screening. Metabolomics, 12(11), 166

    Article  CAS  Google Scholar 

  • Doherty, J. R., & Cleveland, J. L. (2013). Targeting lactate metabolism for cancer therapeutics. Journal of Clinical Investigation, 123, 3685–3692.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Dong, J., Cai, X., Zhao, L., Xue, X., Zou, L., Zhang, X., & Liang, X. (2010). Lysophosphatidylcholine profiling of plasma: Discrimination of isomers and discovery of lung cancer biomarkers. Metabolomics, 6, 478–488.

    Article  CAS  Google Scholar 

  • Dunn, W. B., Broadhurst, D. I., Atherton, H. J., Goodacre, R., & Griffin, J. L. (2011). Systems level studies of mammalian metabolomes: the roles of mass spectrometry and nuclear magnetic resonance spectroscopy. Chemical Society Reviews, 40, 387–426.

    Article  PubMed  CAS  Google Scholar 

  • Emwas, A. H. (2015). The strengths and weaknesses of NMR spectroscopy and mass spectrometry with particular focus on metabolomics research. Methods in Molecular Biology, 1277, 161–193.

    Article  PubMed  CAS  Google Scholar 

  • Emwas, A.-H. M., Salek, R. M., Griffin, J. L., & Merzaban, J. (2013). NMR-based metabolomics in human disease diagnosis: applications, limitations, and recommendations. Metabolomics, 9, 1048–1072.

    Article  CAS  Google Scholar 

  • Fan, T. W., Lane, A. N., & Higashi, R. M. (2016). Stable isotope resolved metabolomics studies in ex vivo tissue slices. Bio-protocol, 6(3), e1730.

    Article  PubMed  PubMed Central  Google Scholar 

  • Fan, T. W., Lane, A. N., Higashi, R. M., Farag, M. A., Gao, H., Bousamra, M., & Miller, D. M. (2009). Altered regulation of metabolic pathways in human lung cancer discerned by (13)C stable isotope-resolved metabolomics (SIRM). Molecular Cancer, 8, 41.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Fan, T. W.-M., Lane, A. N., Higashi, R. M., & Yan, J. (2011). Stable isotope resolved metabolomics of lung cancer in a SCID mouse model. Metabolomics, 7, 257–269.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Ferruzzi, E., Franceschini, R., Cazzolato, G., Geroni, C., Fowst, C., Pastorino, U., … Gion, M. (2003). Blood glutathione as a surrogate marker of cancer tissue glutathione S-transferase activity in non-small cell lung cancer and squamous cell carcinoma of the head and neck. European Journal of Cancer, 39, 1019–1029.

    Article  PubMed  CAS  Google Scholar 

  • Ginsberg, M. S., Grewal, R. K., & Heelan, R. T. (2007). Lung cancer. Radiologic Clinics of North America, 45, 21–43.

    Article  PubMed  Google Scholar 

  • Guo, Y., Wang, X., Qiu, L., Qin, X., Liu, H., Wang, Y., … Li, Z. (2012). Probing gender-specific lipid metabolites and diagnostic biomarkers for lung cancer using Fourier transform ion cyclotron resonance mass spectrometry. Clinica Chimca Acta, 414, 135–141.

    Article  CAS  Google Scholar 

  • Halket, J. M., Waterman, D., Przyborowska, A. M., Patel, R. K., Fraser, P. D., & Bramley, P. M. (2005). Chemical derivatization and mass spectral libraries in metabolic profiling by GC/MS and LC/MS/MS. Journal of Experimental Botany 56(410), 219–243.

    Article  PubMed  CAS  Google Scholar 

  • Hao, D., Sarfaraz, M. O., Farshidfar, F., Bebb, D. G., Lee, C. Y., Card, C. M., … Weljie, A. M. (2016a). Erratum to: Temporal characterization of serum metabolite signatures in lung cancer patients undergoing treatment. Metabolomics, 12, 58.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Hao, D., Sarfaraz, M. O., Farshidfar, F., Bebb, D. G., Lee, C. Y., Card, C. M., … Weljie, A. M. (2016b). Temporal characterization of serum metabolite signatures in lung cancer patients undergoing treatment. Metabolomics, 12, 58.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Hart, P. H., Townley, S. L., Grimbaldeston, M. A., Khalil, Z., & Finlay-Jones, J. J. (2002). Mast cells, neuropeptides, histamine, and prostaglandins in UV-induced systemic immunosuppression. Methods, 28, 79–89.

    Article  PubMed  CAS  Google Scholar 

  • Hassanein, M., Callison, J. C., Callaway-Lane, C., Aldrich, M. C., Grogan, E. L., & Massion, P. P. (2012). The state of molecular biomarkers for the early detection of lung cancer. Cancer Prevention Research, 5, 992–1006.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Haznadar, M., Cai, Q., Krausz, K. W., Bowman, E. D., Margono, E., Noro, R., … Harris, C. C. (2016). Urinary metabolite risk biomarkers of lung cancer: A prospective cohort study. Cancer Epidemiology and Prevention Biomarkers, 25, 978–986.

    Article  CAS  Google Scholar 

  • Higashi, R. M., Fan, T. W.-M., Lorkiewicz, P. K., Moseley, H. N. B., & Lane, A. N. (2014). Stable isotope-labeled tracers for metabolic pathway elucidation by GC-MS and FT-MS. In D. Raftery (Ed.), Mass spectrometry in metabolomics: Methods and protocols. New York: Springer.

    Google Scholar 

  • Hirayama, A., Kami, K., Sugimoto, M., Sugawara, M., Toki, N., Onozuka, H., … Esumi, H. (2009). Quantitative metabolome profiling of colon and stomach cancer microenvironment by capillary electrophoresis time-of-flight mass spectrometry. Cancer Research, 69, 4918.

    Article  PubMed  CAS  Google Scholar 

  • Hirsch, H. A., Iliopoulos, D., Joshi, A., Zhang, Y., Jaeger, S. A., Bulyk, M., … Struhl, K. (2010). A transcriptional signature and common gene networks link cancer with lipid metabolism and diverse human diseases. Cancer Cell, 17, 348–361.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Hori, S., Nishiumi, S., Kobayashi, K., Shinohara, M., Hatakeyama, Y., Kotani, Y., … Yoshida, M. (2011). A metabolomic approach to lung cancer. Lung Cancer, 74, 284–292.

    Article  PubMed  Google Scholar 

  • Hornak, J. P. (1996–2002). The basics of NMR.

  • Hsieh, A. H., Tahkar, H., Koczwara, B., Kichenadasse, G., Beckmann, K., Karapetis, C., & Sukumaran, S. (2017). Pre-treatment serum lactate dehydrogenase as a biomarker in small cell lung cancer. Asia-Pacific Journal of Clinical Oncology, 14(2), e64–e70

    Article  PubMed  Google Scholar 

  • Hu, H., Takano, N., Xiang, L., Gilkes, D. M., Luo, W., & Semenza, G. L. (2014). Hypoxia-inducible factors enhance glutamate signaling in cancer cells. Oncotarget, 5, 8853.

    PubMed  PubMed Central  Google Scholar 

  • Ilonen, I. K., Räsänen, J. V., Sihvo, E. I., Knuuttila, A., Salmenkivi, K. M., Ahotupa, M. O., … Salo, J. A. (2009). Oxidative stress in non-small cell lung cancer: Role of nicotinamide adenine dinucleotide phosphate oxidase and glutathione. Acta Oncologica, 48, 1054–1061.

    Article  PubMed  CAS  Google Scholar 

  • Jackman, D. M., & Johnson, B. E. (2005). Small-cell lung cancer. The Lancet, 366, 1385–1396.

    Article  CAS  Google Scholar 

  • James, T. L. (1998). Fundamentals of NMR (pp. 1–31). San Francisco: Department of Pharmaceutical Chemistry, University of California.

    Google Scholar 

  • Kami, K., Fujimori, T., Sato, H., Sato, M., Yamamoto, H., Ohashi, Y., … Ochiai, A. (2013). Metabolomic profiling of lung and prostate tumor tissues by capillary electrophoresis time-of-flight mass spectrometry. Metabolomics, 9, 444–453.

    Article  PubMed  CAS  Google Scholar 

  • Kaneko, K., Smetana-Just, U., Matsui, M., Young, A. R., John, S., Norval, M., & Walker, S. L. (2008). cis-Urocanic acid initiates gene transcription in primary human keratinocytes. The Journal of Immunology, 181, 217–224.

    Article  PubMed  CAS  Google Scholar 

  • Kantae, V., Krekels, E. H., Esdonk, M. J., Lindenburg, P., Harms, A. C., Knibbe, C. A., … Hankemeier, T. (2017). Integration of pharmacometabolomics with pharmacokinetics and pharmacodynamics: towards personalized drug therapy. Metabolomics, 13, 9.

    Article  PubMed  CAS  Google Scholar 

  • Kaspar, H., Dettmer, K., Gronwald, W., & Oefner, P. J. (2008). Automated GC–MS analysis of free amino acids in biological fluids. Journal of Chromatography B, 870, 222–232.

    Article  CAS  Google Scholar 

  • Khalil, Z., Townley, S. L., Grimbaldeston, M. A., Finlay-Jones, J. J., & Hart, P. H. (2001). cis-Urocanic acid stimulates neuropeptide release from peripheral sensory nerves. Journal of Investigative Dermatology, 117, 886–891.

    Article  PubMed  CAS  Google Scholar 

  • Kim, A. W., Batus, M., Myint, R., Fidler, M. J., Basu, S., Bonomi, P., … Mcintire, M. (2011). Prognostic value of xanthine oxidoreductase expression in patients with non-small cell lung cancer. Lung Cancer, 71, 186–190.

    Article  PubMed  Google Scholar 

  • Kim, K.-R., Park, H.-G., Paik, M.-J., Ryu, H.-S., Oh, K. S., Myung, S.-W., & Liebich, H. M. (1998). Gas chromatographic profiling and pattern recognition analysis of urinary organic acids from uterine myoma patients and cervical cancer patients. Journal of Chromatography B: Biomedical Sciences and Applications, 712, 11–22.

    Article  PubMed  CAS  Google Scholar 

  • Lane, A. N., & Fan, T. W. (2017). NMR-based stable isotope resolved metabolomics in systems biochemistry. Archives of Biochemistry and Biophysics, 628, 123–131.

    Article  PubMed  CAS  PubMed Central  Google Scholar 

  • Lane, A. N., Fan, T. W., Bousamra, M. 2nd, Higashi, R. M., Yan, J., & Miller, D. M. (2011). Stable isotope-resolved metabolomics (SIRM) in cancer research with clinical application to nonsmall cell lung cancer. OMICS: A Journal of Integrative Biology, 15, 173–182.

    Article  PubMed  CAS  Google Scholar 

  • Lane, A. N., & Fan, T. W. M. (2007). Quantification and identification of isotopomer distributions of metabolites in crude cell extracts using 1H TOCSY. Metabolomics, 3, 79–86.

    Article  CAS  Google Scholar 

  • Lane, A. N., Fan, T. W. M., & Higashi, R. M. (2008). Isotopomer-based metabolomic analysis by NMR and mass spectrometry. Methods in Cell Biology, 84, 541–588.

    Article  PubMed  CAS  Google Scholar 

  • Li, Y., Song, X., Zhao, X., Zou, L., & Xu, G. (2014). Serum metabolic profiling study of lung cancer using ultra high performance liquid chromatography/quadrupole time-of-flight mass spectrometry. Journal of Chromatography B, 966, 147–153.

    Article  CAS  Google Scholar 

  • Long, F., Su, J.-H., Liang, B., Su, L.-L., & Jiang, S.-J. (2015). Identification of gene biomarkers for distinguishing small-cell lung cancer from non-small-cell lung cancer using a network-based approach. BioMed Research International, 2015, 685303

    PubMed  PubMed Central  Google Scholar 

  • Lu, W., Su, X., Klein, M. S., Lewis, I. A., Fiehn, O., & Rabinowitz, J. D. (2017). Metabolite measurement: Pitfalls to avoid and practices to follow. Annual Review of Biochemistry, 86, 277–304.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Mathe, E. A., Patterson, A. D., Haznadar, M., Manna, S. K., Krausz, K. W., Bowman, E. D., … Harris, C. C. (2014). Noninvasive urinary metabolomic profiling identifies diagnostic and prognostic markers in lung cancer. Cancer Research, 74, 3259–3270.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Medes, G., Thomas, A., & Weinhouse, S. (1953). Metabolism of neoplastic tissue. IV. A study of lipid synthesis in neoplastic tissue slices in vitro. Cancer Research, 13, 27.

    PubMed  CAS  Google Scholar 

  • Miyagi, Y., Higashiyama, M., Gochi, A., Akaike, M., Ishikawa, T., Miura, T., … Okamoto, N. (2011). Plasma free amino acid profiling of five types of cancer patients and its application for early detection. PLoS ONE, 6, e24143.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Miyamoto, S., Taylor, S. L., Barupal, D. K., Taguchi, A., Wohlgemuth, G., Wikoff, W. R., … Fiehn, O. (2015). Systemic Metabolomic Changes in Blood Samples of Lung Cancer Patients Identified by Gas Chromatography Time-of-Flight Mass Spectrometry. Metabolites, 5,, 192–210.

    Article  CAS  Google Scholar 

  • Miyoshi, T., Kondo, K., Fujino, H., Takahashi, Y., Sawada, N., Sakiyama, S. … Monden, Y. (2005). Thymidylate synthase and dihydropyrimidine dehydrogenase in non-small cell lung cancer: Relationship between mRNA expression and activity. Anticancer Research, 25, 923–930.

    PubMed  CAS  Google Scholar 

  • Moestue, S., Sitter, B., Frost Bathen, T., Tessem, M.B., & Susann Gribbestad, I. (2011). HR MAS MR spectroscopy in metabolic characterization of cancer. Current Topics in Medicinal Chemistry, 11, 2–26.

    Article  PubMed  CAS  Google Scholar 

  • Morris, S. M. (2004). Enzymes of arginine metabolism. The Journal of Nutrition, 134, 2743S–2747S.

    Article  PubMed  CAS  Google Scholar 

  • Muntoni, S., Atzori, L., Mereu, R., Satta, G., Macis, M. D., Congia, M., Tedde, A., & Desogus, A. (2009). Serum lipoproteins and cancer. Nutrition, Metabolism and Cardiovascular Diseases, 19, 218–225.

    Article  PubMed  CAS  Google Scholar 

  • Musharraf, S. G., Mazhar, S., Choudhary, M. I., Rizi, N., & Atta, U. R., R (2015). Plasma metabolite profiling and chemometric analyses of lung cancer along with three controls through gas chromatography-mass spectrometry. Scientific Reports, 5, 8607.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • O’malley, S. S., Wu, R., Mayne, S. T., & Jatlow, P. I. (2014). Smoking cessation is followed by increases in serum bilirubin, an endogenous antioxidant associated with lower risk of lung cancer and cardiovascular disease. Nicotine & Tobacco Research, 16, 1145–1149.

    Article  CAS  Google Scholar 

  • O’shea, K., Cameron, S. J., Lewis, K. E., Lu, C., & Mur, L. A. (2016). Metabolomic-based biomarker discovery for non-invasive lung cancer screening: A case study. Biochimica et Biophysica Acta (BBA)-General Subjects, 1860, 2682–2687.

    Article  CAS  Google Scholar 

  • Pamungkas, A. D., Park, C., Lee, S., Jee, S. H., & Park, Y. H. (2016). High resolution metabolomics to discriminate compounds in serum of male lung cancer patients in South Korea. Respiratory Research, 17, 100.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Potton, E., Mccaughan, F., & Janes, S. (2009). Chronic obstructive pulmonary disease and lung cancer. Respiratory Medicine: COPD Update, 5,, 34–37.

    Google Scholar 

  • Puchades-Carrasco, L., Jantus-Lewintre, E., Pérez-Rambla, C., García-García, F., Lucas, R., Calabuig, S., … Pineda-Lucena, A. (2016). Serum metabolomic profiling facilitates the non-invasive identification of metabolic biomarkers associated with the onset and progression of non-small cell lung cancer. Oncotarget, 7, 12904.

    Article  PubMed  PubMed Central  Google Scholar 

  • Reddy, A. V., Killampalli, L. K., Prakash, A. R., Naag, S., Sreenath, G., & Biraggari, S. K. (2016). Analysis of lipid profile in cancer patients, smokers, and nonsmokers. Dental Research Journal, 13, 494–499.

    Article  PubMed  PubMed Central  Google Scholar 

  • Rocha, C. M., Barros, A. S., Goodfellow, B. J., Carreira, I. M., Gomes, A., Sousa, V., … Duarte, I. F. (2015). NMR metabolomics of human lung tumours reveals distinct metabolic signatures for adenocarcinoma and squamous cell carcinoma. Carcinogenesis, 36, 68–75.

    Article  PubMed  CAS  Google Scholar 

  • Sayin, V. I., Ibrahim, M. X., Larsson, E., Nilsson, J. A., Lindahl, P., & Bergo, M. O. (2014). Antioxidants accelerate lung cancer progression in mice. Science Translational Medicine, 6, 221ra15–221ra15.

    Article  PubMed  CAS  Google Scholar 

  • Schauer, R. (2004). Sialic acids: fascinating sugars in higher animals and man. Zoology, 107, 49–64.

    Article  PubMed  CAS  Google Scholar 

  • Schmid, S., Kübler, M., Ayata, C. K., Lazar, Z., Haager, B., Hoßfeld, M., … Wiesemann, S. (2015). Altered purinergic signaling in the tumor associated immunologic microenvironment in metastasized non-small-cell lung cancer. Lung Cancer, 90, 516–521.

    Article  PubMed  Google Scholar 

  • Sellers, K., Fox, M. P., Bousamra, M. 2nd, Slone, S. P., Higashi, R. M., Miller, D. M., … Fan, T. W. (2015). Pyruvate carboxylase is critical for non-small-cell lung cancer proliferation. The Journal of Clinical Investigation, 125, 687–698.

    Article  PubMed  PubMed Central  Google Scholar 

  • Shingyoji, M., Iizasa, T., Higashiyama, M., Imamura, F., Saruki, N., Imaizumi, A., Yamamoto, H., … Mitsushima, T. (2013). The significance and robustness of a plasma free amino acid (PFAA) profile-based multiplex function for detecting lung cancer. BMC Cancer, 13, 77.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Shintani, Y., Inoue, M., Funakoshi, Y., Matsumura, A., Ohta, M., Maeda, H., & Okumura, M. (2011). Low dihydropyrimidine dehydrogenase correlates with prolonged survival in patients with lung adenocarcinoma treated with 5-fluorouracil. Anticancer Research, 31, 4665–4671.

    PubMed  CAS  Google Scholar 

  • Siegel, R. L., Miller, K. D., & Jemal, A. (2018). Cancer statistics, 2018. CA: A Cancer Journal for Clinicians, 68, 7–30.

    Google Scholar 

  • Simopoulos, A. P. (2002). The importance of the ratio of omega-6/omega-3 essential fatty acids. Biomedicine & Pharmacotherapy, 56, 365–379.

    Article  CAS  Google Scholar 

  • Simopoulos, A. P. (2008). The importance of the omega-6/omega-3 fatty acid ratio in cardiovascular disease and other chronic diseases. Experimental Biology and Medicine, 233, 674–688.

    Article  PubMed  CAS  Google Scholar 

  • Snyder, R. (2012). Leukemia and benzene. International Journal of Environmental Research and Public Health, 9, 2875–2893.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Stringer, K. A., Mckay, R. T., Karnovsky, A., Quemerais, B., & Lacy, P. (2016). Metabolomics and its application to acute lung diseases. Frontiers in Immunology, 7, 44.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Takeuchi, T., Fujiki, H., & Kameya, T. (1981). Characterization of amylases produced by tumors. Clinical Chemistry, 27, 556–559.

    PubMed  CAS  Google Scholar 

  • Theodoridis, G., Gika, H. G. & Wilson, I. D. (2011). Mass spectrometry-based holistic analytical approaches for metabolite profiling in systems biology studies. Mass Spectrometry Reviews, 30, 884–906.

    PubMed  CAS  Google Scholar 

  • Traverso, N., Ricciarelli, R., Nitti, M., Marengo, B., Furfaro, A. L., Pronzato, M. A., Marinari, U. M., & Domenicotti, C. (2013). Role of glutathione in cancer progression and chemoresistance. Oxidative Medicine and Cellular Longevity, 2013, 97293.

    Article  CAS  Google Scholar 

  • Tsun, Z. Y., & Possemato, R. (2015). Amino acid management in cancer. Seminars in Cell & Developmental Biology, 43, 22–32.

    Article  CAS  Google Scholar 

  • Tuna, D., Sobolewski, A. L., & Domcke, W. (2014). Photochemical mechanisms of radiationless deactivation processes in urocanic acid. The Journal of Physical Chemistry B, 118, 976–985.

    Article  PubMed  CAS  Google Scholar 

  • Ubhi, B. K., Riley, J. H., Shaw, P. A., Lomas, D. A., Tal-Singer, R., Macnee, W., Griffin, J. L., & Connor, S. C. (2012). Metabolic profiling detects biomarkers of protein degradation in COPD patients. European Respiratory Journal, 40, 345–355.

    Article  PubMed  CAS  Google Scholar 

  • van den Heuvel, A. P., Jing, J., Wooster, R. F., & Bachman, K. E. (2012). Analysis of glutamine dependency in non-small cell lung cancer: GLS1 splice variant GAC is essential for cancer cell growth. Cancer Biology & Therapy, 13, 1185–1194.

    Article  CAS  Google Scholar 

  • Vander Heiden, M. G., Cantley, L. C., & Thompson, C. B. (2009). Understanding the Warburg effect: The metabolic requirements of cell proliferation. Science 324, 1029–1033.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Vulimiri, S. V., Misra, M., Hamm, J. T., Mitchell, M., & Berger, A. & Berger, A. (2009). Effects of mainstream cigarette smoke on the global metabolome of human lung epithelial cells. Chemical Research in Toxicology, 22, 492–503.

    Article  PubMed  CAS  Google Scholar 

  • Wang, C., Dong, R., Wang, X., Lian, A., Chi, C., Ke, C., … Li, E. (2014). Exhaled volatile organic compounds as lung cancer biomarkers during one-lung ventilation. Scientific Reports, 4, 7312.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Wang, H., Yang, L., Zou, L., Huang, D., Guo, Y., Pan, M., Tan, Y., …, Zhong, N. (2012). Association between chronic obstructive pulmonary disease and lung cancer: A case-control study in Southern Chinese and a meta-analysis. PLoS ONE, 7, e46144.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Wang, L., Ling, T., Liu, S., Mao, S., Ling, Y., Liu, D., He, X., & Wang, X. (2013). Metabonomic profiling of serum and urine by 1H NMR-based spectroscopy discriminates patients with chronic obstructive pulmonary disease and healthy individuals. PLoS ONE, 8, e65675.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Warburg, O. (1956). On the origin of cancer cells. Science, 123, 309.

    Article  PubMed  CAS  Google Scholar 

  • Wen, C. P., Zhang, F., Liang, D., Wen, C., Gu, J., Skinner, H. D., … Huang, M. (2015). The ability of bilirubin in identifying smokers with higher risk of lung cancer: a large cohort study in conjunction with global metabolomic profiling. Clinical Cancer Research, 21, 193–200.

    Article  PubMed  CAS  Google Scholar 

  • Wikoff, W .R., Grapov, D., Fahrmann, J. F., DeFelice, B., Rom, W. N., Pass, H. I., … Kelly, K. (2015b). Diacetylspermine is a novel prediagnostic serum biomarker for non-small-cell lung cancer and has additive performance with pro-surfactant protein B. Journal of Clinical Oncology, 33, 3880–3886.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Wikoff, W .R., Grapov, D., Fahrmann, J. F., DeFelice, B., Rom, W. N., Pass, H. I., … Kelly, K.. (2015a). Metabolomic markers of altered nucleotide metabolism in early stage adenocarcinoma. Cancer Prevention Research 8, 410–418.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Wishart, D. S. (2015). Is cancer a genetic disease or a metabolic disease? EBioMedicine, 2, 478–479.

    Article  PubMed  PubMed Central  Google Scholar 

  • Wiwanitkit, V., Suwansaksri, J. & Soogarun, S. (2005). Monitoring of urine trans, trans-muconic acid level among smokers and non-smokers. Respiratory Medicine, 99, 788–791.

    Article  PubMed  Google Scholar 

  • Wong, M. C. S., Lao, X. Q., Ho, K. F., Goggins, W. B. & Shelly, L. A. (2017). Incidence and mortality of lung cancer: Global trends and association with socioeconomic status. Scientific Reports, 7, 14300.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Xie, H., Hanai, J., Ren, J. G., Kats, L., Burgess, K., Bhargava, P., … Seth, P. (2014). Targeting lactate dehydrogenase—A inhibits tumorigenesis and tumor progression in mouse models of lung cancer and impacts tumor-initiating cells. Cell Metabolism, 19, 795–809.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Yao, H., & Rahman, I. (2009). Current concepts on the role of inflammation in COPD and lung cancer. Current Opinion in Pharmacology, 9, 375–383.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Yeh, C.-S., Wang, J.-Y., Cheng, T.-L., Juan, C.-H., Wu, C.-H., & Lin, S.-R. (2006). Fatty acid metabolism pathway play an important role in carcinogenesis of human colorectal cancers by Microarray-Bioinformatics analysis. Cancer Letters, 233, 297–308.

    Article  PubMed  CAS  Google Scholar 

  • Yu, L., Li, K., & Zhang, X. (2017). Next-generation metabolomics in lung cancer diagnosis, treatment and precision medicine: mini review. Oncotarget, 8, 115774–115786.

    PubMed  PubMed Central  Google Scholar 

  • Yu, X., Wu, Q., Lu, W., Wang, Y., Ma, X., Chen, Z., & Yan, C. (2013). Metabonomics study of lung cancer cells based on liquid l chromatography-mass spectrometry. Chinese Journal of Chromatography, 31, 691–696.

    Article  PubMed  CAS  Google Scholar 

  • Yuan, J. M., Gao, Y. T., Murphy, S. E., Carmella, S. G., Wang, R., Zhong, Y., … Hecht, S. S. (2011). Urinary levels of cigarette smoke constituent metabolites are prospectively associated with lung cancer development in smokers. Cancer Research, 71, 6749–6757.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Zhang, A., Sun, H., Wang, P., Han, Y., & Wang, X. (2012a). Modern analytical techniques in metabolomics analysis. Analyst, 137, 293–300.

    Article  PubMed  CAS  Google Scholar 

  • Zhang, F., & Du, G. (2012). Dysregulated lipid metabolism in cancer. World Journal of Biological Chemistry, 3, 167–174.

    Article  PubMed  PubMed Central  Google Scholar 

  • Zhang, W. C., Shyh-Chang, N., Yang, H., Rai, A., Umashankar, S., Ma, S., … Lim, B. (2012b). Glycine decarboxylase activity drives non-small cell lung cancer tumor-initiating cells and tumorigenesis. Cell, 148, 259–272.

    Article  PubMed  CAS  Google Scholar 

  • Zhang, X., Zhu, X., Wang, C., Zhang, H., & Cai, Z. (2016). Non-targeted and targeted metabolomics approaches to diagnosing lung cancer and predicting patient prognosis. Oncotarget, 7, 63437.

    PubMed  PubMed Central  Google Scholar 

  • Zhou, W., Capello, M., Fredolini, C., Racanicchi, L., Piemonti, L., Liotta, L. A., Novelli, F., & Petricoin, E. F. (2012). Proteomic analysis reveals Warburg effect and anomalous metabolism of glutamine in pancreatic cancer cells. Journal of Proteome Research, 11, 554–563.

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgements

HBF acknowledges partial support by the National Institutes of Health/National Cancer Institute Grant R15CA203605.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Hermann B. Frieboes.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Research involving human and animal participants

This work did not involve human participants or animals.

Informed consent

Is not applicable to this work.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Bamji-Stocke, S., van Berkel, V., Miller, D.M. et al. A review of metabolism-associated biomarkers in lung cancer diagnosis and treatment. Metabolomics 14, 81 (2018). https://doi.org/10.1007/s11306-018-1376-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1007/s11306-018-1376-2

Keywords

Navigation